Dover Advisors LLC Sells 1,411 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Dover Advisors LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 26.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,876 shares of the healthcare conglomerate’s stock after selling 1,411 shares during the quarter. UnitedHealth Group makes up approximately 2.7% of Dover Advisors LLC’s investment portfolio, making the stock its 5th largest holding. Dover Advisors LLC’s holdings in UnitedHealth Group were worth $2,041,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. International Assets Investment Management LLC increased its position in UnitedHealth Group by 53,573.1% during the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock worth $1,238,515,000 after acquiring an additional 2,348,107 shares during the period. Jennison Associates LLC boosted its stake in shares of UnitedHealth Group by 49.3% in the fourth quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock valued at $1,904,670,000 after buying an additional 1,195,352 shares during the period. Mawer Investment Management Ltd. increased its stake in UnitedHealth Group by 75.0% during the 3rd quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock worth $1,014,002,000 after acquiring an additional 862,024 shares during the period. California Public Employees Retirement System grew its stake in UnitedHealth Group by 35.9% during the fourth quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock worth $1,627,311,000 after buying an additional 815,822 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its position in shares of UnitedHealth Group by 20.1% in the 3rd quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock valued at $1,879,245,000 after buying an additional 623,631 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Activity

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $1.49 during trading on Friday, hitting $495.35. The company’s stock had a trading volume of 2,727,016 shares, compared to its average volume of 5,623,667. The business has a fifty day moving average of $485.84 and a 200-day moving average of $514.07. The company has a market cap of $455.76 billion, a PE ratio of 30.28, a P/E/G ratio of 1.43 and a beta of 0.54. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the previous year, the business posted $6.26 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Analysts Set New Price Targets

Several research firms have weighed in on UNH. Bank of America restated a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Wells Fargo & Company cut their target price on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Royal Bank of Canada lowered their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft raised their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Finally, TD Cowen lowered their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Four analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.